Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Polybrominated Diphenyl Ethers
95%
Gut Microbiome
92%
Diabetes
52%
Obesity
46%
Flame Retardant
39%
Constitutive Androstane Receptor
34%
Pregnane X Receptor
34%
Early-life Exposure
24%
Dysbiosis
22%
Tetrabromobisphenol A (TBBPA)
19%
Microbial Metabolites
15%
Type 2 Diabetes Mellitus (T2DM)
14%
Adulthood
11%
Short-chain Fatty Acids
9%
Microbes
9%
Nuclear Receptor
9%
Microbial Signatures
9%
Intestinal Inflammation
9%
Liver
9%
Mimicry
9%
Tryptophan Metabolism
8%
Social Burden
8%
Receptor Signaling
8%
Economic Burden
8%
Graves
8%
Inflammation
7%
Diabetic
7%
Indole
7%
Metabolic Syndrome
7%
Tryptophan
7%
Delayed Onset
6%
Complex Disease
6%
Pharmacology, Toxicology and Pharmaceutical Science
Polybrominated Diphenyl Ether
100%
Microbiome
92%
Constitutive Androstane Receptor
39%
Flame Retardant
39%
Pregnane X Receptor
39%
Dysbiosis
25%
Tetrabromobisphenol A
22%
Tryptophan
22%
Receptor
18%
Indole Derivative
14%
Inflammation
12%
Short Chain Fatty Acid
11%
Enteritis
11%
Cell Nucleus Receptor
11%
Maturity Onset Diabetes of the Young
11%
Diabetes Mellitus
7%
Metabolic Syndrome X
7%
Disease
5%
Non Insulin Dependent Diabetes Mellitus
5%
Diet Induced Obesity
5%
Anti-Inflammatory Drug
5%
Liver Injury
5%
Indolepropionic Acid
5%
Intestine Flora
5%
Medicine and Dentistry
Flame Retardant
39%
Constitutive Androstane Receptor
39%
Pregnane X Receptor
39%
Gut Microbiome
39%
Polybrominated Diphenyl Ether
33%
Tetrabromobisphenol A
22%
Maturity Onset Diabetes of the Young
16%
Short Chain Fatty Acid
11%
Mediator
11%
Enteritis
11%
High Fat Food
11%
Cell Nucleus Receptor
11%
Dysbiosis
11%
Tryptophan Metabolism
11%
Gut
11%
Gut Microbiota
5%
Immunocompetent Cell
5%
Metabolite
5%
Indolepropionic Acid
5%
Anti-Inflammatory Drug
5%
Liver Injury
5%
Diabetes
5%
Immunological Tolerance
5%
Hormone Release
5%
Diet Induced Obesity
5%